Tag Archives: HIV

FDA: The Year in Review (2012)

On 10 Dec 2012, the FDA released a report titled, “FY 2012 Innovative Drug Approvals,” which discusses the FDA’s 2012 novel drug approvals and the focus on the advancement of regulatory science in to improve the drug approval process. Thirty-five … Continue reading

Posted in FDA, Industry News | Tagged , , , , , , , , , , , , , | Comments Off on FDA: The Year in Review (2012)

FDA’s New Guidances for November 2012

Several new guidance documents were released by FDA in November 2012, covering a wide range of subjects.  The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Artificial Pancreas Device Systems Highly Multiplexed Microbiological/Medical Countermeasure In Vitro … Continue reading

Posted in Clinical Trials, FDA, Regulatory Strategy | Tagged , , , , , , , , , , | Comments Off on FDA’s New Guidances for November 2012

Clinical Trials in the Facebook Age

On 07 Jun 2011, Pfizer initiated a clinical trial pilot to assess safety and efficacy of Detrol LA, which is a treatment for overactive bladder (OAB).  The trial, REMOTE (Research on Electronic Monitoring of OAB Treatment Experience), was the first … Continue reading

Posted in Clinical Trials, Industry News, Social Media | Tagged , , , , , , , , | Comments Off on Clinical Trials in the Facebook Age

Recap of the DIA Annual Meeting 2011

The 47th Annual DIA Meeting was held on 19-23 June 2011 in Chicago and was a great success with thousands of attendees from the health care industry and regulators from around the world including representatives from the FDA, the EMA, … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Recap of the DIA Annual Meeting 2011